
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Kidney non-tumor
Tubular and interstitial diseases
Granulomatous interstitial nephritis
Reviewers: Nikhil Sangle, M.D. (see Reviewers page)
Revised: 25 December 2012, last major update August 2012
Copyright: (c) 2003-2012, PathologyOutlines.com, Inc.
General
=========================================================================
● Rare disorder, often due to drugs (aspirin, gentamycin), infections (E. coli, mycobacteria), sarcoidosis (Am J Kidney Dis 2012;59:303), Wegener’s granulomatosis, oxalosis secondary to intestinal bypass (Hum Pathol 1995;26:1347)
Case reports
=========================================================================
● 23 year old woman with tuberculosis (Clin Nephrol 2011;76:487)
● 42 year old man with rising serum creatinine 18 months after initiation of adalimumab therapy for ankylosing spondylitis (Am J Kidney Dis 2010;56:e17)
● 70 year old woman taking carbamazepine (Clin Exp Nephrol 2012;16:168)
Treatment
=========================================================================
● Steroids for idiopathic disease
Micro description
=========================================================================
● Usually granulomas, T cells and macrophages; rarely neutrophils
Micro images
=========================================================================
Various images
Adalimumab related
Carbamazepine related
Cryptococcus infection related
Nitrofurantoin related
Renal sarcoidosis
Tuberculosis infection related
End of Kidney non-tumor > Tubular and interstitial diseases > Granulomatous interstitial nephritis
Ref Updated: 8/17/12
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).